GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical Transplantation, Wiley, Vol. 31, No. 9 ( 2017-09)
    Abstract: The Sc andinavian he art transplant everolimus d e novo st u dy with ear l y calcineurin inhibitors avoidanc e ( SCHEDULE ) trial was a 12 month, randomized, open‐label, parallel‐group trial that compared everolimus ( EVR ; n=56) to conventional CsA (n=59) immunosuppression. Previously, we reported that EVR outperformed CsA in improving renal function and coronary artery vasculopathy, despite a higher rejection rate with EVR . This study aimed to compare the effects of these treatments on quality of life (QoL). Within five post‐operative days, patients (mean age 50±13 years, 27% women) were randomized to EVR or a standard CsA dosage (CsA group). This study assessed quality of life (QoL), based on the Short Form‐36, EuroQol‐5D, and Beck Depression Inventory ( BDI ). Assessments were performed pre‐ HT x and 12 and 36 months post‐ HT x. At 12 and 36 months, the groups showed similar improvements in Short Form‐36 measures (at pre‐ HT x, 12 and 36 months the values were as follows: Physical component summary: EVR : 31.5±110.9, 49.1±9.7, and 47.9±10.6; P 〈 .01; CsA: 32.5±8.2, 48.4±8.5, and 46.5±11.5; P 〈 .01; mental component summary: EVR : 46.0±12.0, 51.7±11.9, and 52.1±13.0; P 〈 .01; CsA: 38.2±12.5, 53.4±7.1, and 54.3±13.0; P 〈 .01); similar decrease in mean BDI ( EVR : 10.9±10.2, 5.4±4.7, and 8.1±9.0; P 〈 .01; CsA: 11.8±7.1, 6.3±5.4, and 6.2±6.5; P 〈 .01); and similar Euro Qol‐improvements. Thus, in this small‐sized study, EVR ‐based and conventional CsA immunosuppressive strategies produced similar QoL improvements.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Clinical Transplantation, Wiley, Vol. 35, No. 7 ( 2021-07)
    Abstract: Few studies, with inconclusive results, have examined the association of anxiety with mortality after heart transplantation (HTx). We examined whether anxiety symptoms, measured several years after HTx, are associated with increased mortality during long‐term follow‐up. Methods Anxiety symptoms were measured with the anxiety subscale of the Symptom Checklist‐90‐R (SCL‐90‐R) in 142 HTx recipients at a mean of 5.7 years (SD: 3.9) after HTx. Anxiety symptoms’ impact on mortality during follow‐up for up to 18.6 years was examined with Cox proportional hazard models. We accounted for relevant sociodemographic and clinical variables, including depressive symptoms (measured by the depression subscale of the SCL‐90‐R), in the multivariate analyses. In additional analyses, we explored the combined effect of anxious and depressive symptomatology. Results Anxiety symptoms were not significantly associated with mortality (univariate analysis: HR (95% CI): 1.04 (0.75–1.45); p  = .813). Exploration of the combined effect of anxious and depressive symptomatology on mortality rendered non‐significant results. Depressive symptoms were independently associated with mortality (multivariate analysis: HR (95% CI): 1.86 (1.07–3.24); p  = .028). Conclusions Depressive symptoms’ negative impact on survival after HTx was confirmed, while anxiety symptoms were not significantly associated with mortality during long‐term follow‐up. Anxiety symptoms’ predictive role after HTx requires further study.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Clinical Transplantation, Wiley, Vol. 30, No. 2 ( 2016-02), p. 161-169
    Abstract: Peak oxygen uptake ( VO 2peak ) is known as the gold standard measure of cardiopulmonary fitness. We therefore hypothesized that measures of physical health would predict long‐term survival in heart transplant recipients ( HT x). Methods This retrospective study investigated survival in two HT x populations; the cardiopulmonary exercise test ( CPET ) cohort comprised 178 HT x patients who completed a VO 2peak test during their annual follow‐up (1990–2003), and the SF ‐36 cohort comprised 133 patients who completed a quality of life questionnaire, SF ‐36v1 (1998–2000). Results Mean ( SD ) age in the CPET cohort was 52 (12) yr and 54 (11) yr in the SF ‐36 cohort. Mean observation time was, respectively, 11 and 10 yr. Mean ( SD ) VO 2peak was 19.6 (5.3) mL/kg/min, and median ( IR ) physical function ( PF ) score was 90 (30). VO 2peak and PF scores were both significant predictors in univariate Cox regression. Multiple Cox regression analyses adjusted for other potential predictors showed that VO 2peak , age, and cardiac allograft vasculopathy ( CAV ) were the most important predictors in the CPET cohort, whereas age, PF score, smoking, and CAV were the most important predictors in the SF ‐36 cohort. In Kaplan–Meier analysis, VO 2peak and PF scores above the median value were related to significant longer survival time. Conclusion Peak oxygen uptake and self‐reported physical health are strong predictors for long‐term survival in HT x recipients. VO 2peak is a crucial measurement and should be more frequently used after HT x.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2007
    In:  Transplantation Vol. 84, No. 1 ( 2007-07-15), p. 97-103
    In: Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 84, No. 1 ( 2007-07-15), p. 97-103
    Type of Medium: Online Resource
    ISSN: 0041-1337
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2007
    detail.hit.zdb_id: 2035395-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: American Journal of Transplantation, Elsevier BV, Vol. 20, No. 12 ( 2020-12), p. 3538-3549
    Type of Medium: Online Resource
    ISSN: 1600-6135
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2020
    detail.hit.zdb_id: 2045621-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 139, No. 19 ( 2019-05-07), p. 2198-2211
    Abstract: There is no consensus on how, when, or at what intensity exercise should be performed after heart transplantation (HTx). We have recently shown that high-intensity interval training (HIT) is safe, well tolerated, and efficacious in the maintenance state after HTx, but studies have not investigated HIT effects in the de novo HTx state. We hypothesized that HIT could be introduced early after HTx and that it could lead to clinically meaningful increases in exercise capacity and health-related quality of life. Methods: This multicenter, prospective, randomized, controlled trial included 81 patients a mean of 11 weeks (range, 7–16 weeks) after an HTx. Patients were randomized 1:1 to 9 months of either HIT (4×4-minute intervals at 85%–95% of peak effort) or moderate-intensity continuous training (60%–80% of peak effort). The primary outcome was the effect of HIT versus moderate-intensity continuous training on the change in aerobic exercise capacity, assessed as the peak oxygen consumption (V o 2 peak). Secondary outcomes included tolerability, safety, adverse events, isokinetic muscular strength, body composition, health-related quality of life, left ventricular function, hemodynamics, endothelial function, and biomarkers. Results: From baseline to follow-up, 96% of patients completed the study. There were no serious exercise-related adverse events. The population comprised 73% men, and the mean±SD age was 49±13 years. At the 1-year follow-up, the HIT group demonstrated greater improvements than the moderate-intensity continuous training group; the groups showed significantly different changes in the V o 2 peak (mean difference between groups, 1.8 mL·kg − 1·min − 1), the anaerobic threshold (0.28 L/min), the peak expiratory flow (11%), and the extensor muscle exercise capacity (464 J). The 1.8-mL·kg − 1·min − 1 difference was equal to ≈0.5 metabolic equivalents, which is regarded as clinically meaningful and relevant. Health-related quality of life was similar between the groups, as indicated by results from the Short Form-36 (version 2), Hospital Anxiety and Depression Scale, and a visual analog scale. Conclusions: We demonstrated that HIT was a safe, efficient exercise method in de novo HTx recipients. HIT, compared with moderate-intensity continuous training, resulted in a clinically significantly greater change in exercise capacity based on the V o 2 peak values (25% versus 15%), anaerobic threshold, peak expiratory flow, and muscular exercise capacity. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier NCT01796379.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2019
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Psychosomatic Medicine, Ovid Technologies (Wolters Kluwer Health), Vol. 81, No. 6 ( 2019-7), p. 513-520
    Abstract: Current understanding of the prognostic impact of depression on mortality after heart transplantation (HTx) is limited. We examined whether depression after HTx is a predictor of mortality during extended follow-up. Subsequently, we explored whether different symptom dimensions of depression could be identified and whether they were differentially associated with mortality. Methods Survival analyses were performed in a sample of 141 HTx recipients assessed for depression, measured by self-report of depressive symptoms (Beck Depression Inventory – version 1A [BDI-1A]), at median 5.0 years after HTx, and followed thereafter for survival status for up to 18.6 years. We used uni- and multivariate Cox proportional hazard models to examine the association of clinically significant depression (BDI-1A total score ≥10), as well as the cognitive-affective and the somatic subscales of the BDI-1A (resulting from principal component analysis) with mortality. In the multivariate analyses, we adjusted for relevant sociodemographic and clinical variables. Results Clinically significant depression was a significant predictor of mortality (hazard ratio = 2.088; 95% confidence interval = 1.366–3.192; p = .001). Clinically significant depression also was an independent predictor of mortality in the multivariate analysis (hazard ratio = 1.982; 95% confidence interval = 1.220–3.217; p = .006). The somatic subscale, but not the cognitive-affective subscale, was significantly associated with increased mortality in univariate analyses, whereas neither of the two subscales was an independent predictor of mortality in the multivariate analysis. Conclusions Depression measured by self-report after HTx is associated with increased mortality during extended follow-up. Clinical utility and predictive validity of specific depression components require further study.
    Type of Medium: Online Resource
    ISSN: 1534-7796 , 0033-3174
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2019
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Health and Quality of Life Outcomes, Springer Science and Business Media LLC, Vol. 18, No. 1 ( 2020-12)
    Abstract: Studies on the effect of high-intensity interval training (HIT) compared with moderate intensity continuous training (MICT) on health-related quality of life (HRQoL) after heart transplantation (HTx) is scarce. No available studies among de novo HTx recipients exists. This study aimed to investigate the effect of HIT vs. MICT on HRQoL in de novo recipients. Methods The HITTS study randomized eighty-one de novo HTx recipients to receive either HIT or MICT (1:1). The HIT intervention were performed with 2–4 interval bouts with an intensity of 85–95% of maximal effort. The MICT group exercised at an intensity of 60–80% of their maximal effort with a duration of 25 min. HRQoL was assessed by the Short Form-36 version 2 (SF-36v2) and the Hospital Anxiety and Depression Scale, mean 11 weeks after surgery and after a nine months’ intervention. The participants recorded their subjective effect of the interventions on their general health and well-being on a numeric visual analogue scale. Clinical examinations and physical tests were performed. Differences between groups were investigated with independent Student t-tests and with Mann-Whitney U tests where appropriate. Within-group differences were analyzed with Paired-Sample t-tests and Wilcoxon Signed Rank tests. Correlations between SF-36 scores and VO 2peak were examined with Pearson’s correlations. Results Seventy-eight participants completed the intervention. Both exercise modes were associated with improved exercise capacity on the physical function scores of HRQoL. Mental health scores remained unchanged. No differences in the change in HRQoL between the groups occurred except for Role Emotional subscale with a larger increase in the HIT arm. Better self-reported physical function was associated with higher VO 2peak and muscle strength. Conclusion HIT and MICT resulted in similar mean changes in HRQoL the first year after HTx. Both groups experienced significant improvements in the physical SF-36v2. Trial registration ClinicalTrials.gov number: NCT01796379 Registered 18 February 2013.
    Type of Medium: Online Resource
    ISSN: 1477-7525
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2098765-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Clinical Transplantation, Wiley, Vol. 31, No. 12 ( 2017-12)
    Abstract: Cognitive impairment is documented early after heart transplantation ( HT x), but we lack data on cognitive function beyond the fourth year post‐transplant. Against the background of good long‐term survival, this knowledge is necessary to improve clinical care throughout the entire post‐transplant period. Methods We assessed cognitive function with a neuropsychological test battery in a sample of HT x recipients ≥16 years post‐transplant. To improve clinical utility, we also applied adapted consensus criteria for Mild Cognitive Impairment ( MCI ). Furthermore, we explored sociodemographic and clinical characteristics possibly related to cognitive function. Results Thirty‐seven subjects were included 20.3 (±3.8) years after HT x. Mean age was 57.5 (±14.2) years, and 18.9% were women. Up to 38.9% exhibited impaired test performance (ie, performance at least 1.5 standard deviations below the normative mean) on several individual cognitive measures, especially on measures of processing speed, executive functions, memory, and language functions. One subject was diagnosed with dementia, and 30.1% qualified for MCI . Those with MCI had lower hemoglobin than those without. Conclusions A substantial proportion of long‐term survivors of HT x might be cognitively impaired. The level of impairment appears comparable to what is defined as MCI in the literature. Modifiable factors related to cognitive impairment might exist.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Clinical Transplantation, Wiley, Vol. 31, No. 4 ( 2017-04)
    Abstract: Studies have shown conflicting results concerning the occurrence of cognitive impairment after successful heart transplantation (HTx). Another unresolved issue is the possible differential impact of immunosuppressants on cognitive function. In this study, we describe cognitive function in a cohort of HTx recipients and subsequently compare cognitive function between subjects on either everolimus‐ or calcineurin inhibitor (CNI)‐based immunosuppression. Methods Cognitive function, covering attention, processing speed, executive functions, memory, and language functions, was assessed with a neuropsychological test battery. Thirty‐seven subjects were included (everolimus group: n=20; CNI group: n=17). The extent of cerebrovascular pathology was assessed with magnetic resonance imaging. Results About 40% of subjects had cognitive impairment, defined as performance at least 1.5 standard deviations below normative mean in one or several cognitive domains. Cerebrovascular pathology was present in 33.3%. There were no statistically significant differences between treatment groups across cognitive domains. Conclusions Given the high prevalence of cognitive impairment in the sample, plus the known negative impact of cognitive impairment on clinical outcome, our results indicate that cognitive assessment should be an integrated part of routine clinical follow‐up after HTx. However, everolimus‐ and CNI‐based immunosuppressive regimens did not show differential impacts on cognitive function.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...